Dr. Jyoti Gupta Anand is a consultant in the Department of Medical Oncology at Yashoda Cancer Institute, Sanjay Nagar, Ghaziabad. She has over 10 years of experience in general medicine and medical oncology.
With D.N.B. in both internal medicine and medical oncology, Dr. Jyoti Gupta Anand is an expert in the field of chemotherapy and medicine-based cancer treatment. Besides this, she has participated in various clinical trials studies as well, apart from contributing to various publications
Educational Qualifications
M.B.B.S., Baba Farid University of Health Sciences & Research, Faridkot
D.N.B. (Internal Medicine), Northern Railway Central Hospital, New Delhi (National Board of Examinations)
D.N.B. (Medical Oncology), Action Cancer Hospital, New Delhi (National Board of Examinations)
Experiences
Junior Resident, Department of General Medicine, NRCH, New Delhi – Feb. 2007-2010
Consultant (Medicine), Shree Jeewan Hospital, New Delhi – 2010-2011
Senior Resident, Department of Neurology, Safdarjung Hospital, New Delhi – 2012-2014
Senior Resident, Department of Medicine, Hindu Rao Hospital & North DMC Medical College, New Delhi – 2014-2015
Assistant Professor, Department of Medicine, Hindu Rao Hospital & North DMC Medical College, New Delhi - Jan. 2015-Mar. 2015
Junior Resident, Department of Medical Oncology, Action Cancer Hospital, New Delhi – 2015-2018
Clinical Associate, Department of Medical Oncology, Action Cancer Hospital, New Delhi – Mar. 2018-Jul. 2018
Associate Consultant, Department of Medical Oncology, Venkateshwar Hospital, New Delhi- 2018-2019
Teacher & thesis co-guide for DNB Medical Oncology students, Action Cancer Hospital- 2019
Consultant, Department of Medical Oncology, Action Cancer Hospital, New Delhi- 2019-2021
Consultant, Department of Medical Oncology, Yashoda Cancer Institute, Sanjay Nagar, Ghaziabad – 2021-Present
Research & Publications
Dissertation, D.N.B. (Medicine), ‘Metabolic Syndrome in North Indian Railway Population - A Study’
Dissertation, D.N.B. (Medical Oncology), ‘A Study of Ki-67 Labelling Index in Breast Cancer Molecular Subtypes & Its Correlation with Local and Regional Relapse’
09810709038